*In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
But, you know, when something sounds too good to be true, it might be, right
Taking GLP-1s appears to alter these areas and change the levels of reward-related neurotransmitters dopamine and glutamate, a review of related studies suggests
How Does Semaglutide Stack Up Against Other Weight Loss Meds
It works by mimicking a hormone called GLP-1 that regulates blood sugar and appetite